Appendix D. Chart Audit Form Preventing Hospital-Acquired Venous Thromboembolism Reviewer _____________________ MR# _________________ Name ___________________ Dx#1 _______Date/Time ___________________ Date of Admission ______________________________ Dx#2 _______Ht: ____________ Wt ____________ BMI ____________ Age ____________ Sex M F Dx#3 _______Service ______________________ Ward/Location _______________________________________________1. Is patient eligible for survey? (i.e., not currently on full anticoagulation)Yes No If No, stop here.2. Assign venous thromboembolism risk (Refer to VTE risk factors table and circle category).Low Moderate High3. Does patient have relative or absolute contraindications to pharmacologic prophylaxis or condition of concern? (circle appropriate category, if present)Yes NoAdequate Prophylaxis Regimens for Each Level of VTE RiskLow RiskModerate RiskHigh riskEarly ambulation.Heparin 5,000 units SC q 8 h orHeparin 7,500 units SC q 12 h orDalteparin 5,000 units SC daily orEnoxaparin 40 mg SC daily orHeparin 5,000 units SC q 12 hours(only for patients with weight <50 kg or age >75 years)and Suggest adding SCDsDalteparin 5,000 units SC daily orEnoxaparin 30 mg SC q 12 hours orEnoxaparin 40 mg SC q day orFondaparinux 2.5 mg SC daily orWarfarin, INR 2-3.and SCDs (unless not feasible)This table is to be used only in audit tools; it is not for use in order sets. Sequential compression devices (SCDs) are appropriate if anticoagulant use is contraindicated.4. Document current prophylaxis ordered.Non Pharmacologic___ Sequential compression device Are these in place and on?_________ Elastic stockingsPharmacologic___ Heparin 5,000 units subcutaneous q 12 hours___ Heparin 7,500 units subcutaneous q 12 hours___ Heparin 5,000 units subcutaneous q 8 hours___ Enoxaparin (Lovenox) 40 mg subcutaneous q day___ Enoxaparin (Lovenox) 30 mg subcutaneous q 12 hours___ Dalteparin (Fragmin) 2,500 units subcutaneous q day___ Dalteparin (Fragmin) 5,000 units subcutaneous daily___ Fondaparinux (Arixtra) 2.5 mg subcutaneous daily ($28.63/day). Start 6 hours post-op.___ Coumadin ______mg daily___ Other ________________________________________________________________________________5. Do the prophylactic measures match the measures in the above table? (Remember that SCDs alone may be appropriate in patients who have contraindications to pharmacologic prophylaxis.)Yes No6. If mismatch, notify physician within 24 hours.Physician notified ____________ Date/Time ____________7. Did physician change order to a matched prophylaxis as a result of the intervention?Yes No8. If no, list reason given below. 9. Final judgment: Was the prophylaxis ordered for the patient at the time of the survey adequate?Yes No Not SureLow RiskModerate RiskHigh riskAmbulatory patient without additional VTE risk factors or expected length of stay <2 daysMinor surgery in patient without additional VTE risk factors (same day surgery or operating room time <30 minutes).Patients who aren't in either the low- or high-risk group (go to the VTE risk factor table below)Elective hip or knee arthroplastyAcute spinal cord injury with paresisMultiple major traumaAbdominal or pelvic surgery for cancer Venous Thromboembolism Risk FactorsAge >50 yearsMyeloproliferative disorderDehydrationCongestive heart failureActive malignancyHormonal replacementModerate to major surgeryPrior history of VTEImpaired mobilityInflammatory bowel diseaseActive rheumatic diseaseSickle cell diseaseEstrogen-based contraceptivesCentral venous catheterAcute or chronic lung diseaseObesityKnown thrombophilic stateVaricose veins/chronic stasisRecent post-partum withimmobilityNephrotic syndromeMyocardial infarction Contraindications or Other Conditions to Consider With Pharmacologic VTE ProphylaxisAbsoluteRelativeOther ConditionsActive hemorrhage.Severe trauma to head or spinal cord with hemorrhage in the last 4 weeks.Other___________________Intracranial hemorrhage within last year.Craniotomy within 2 weeksIntraocular surgery within 2 weeks.Gastrointestinal, genitourinary hemorrhage within the last month.Thrombocytopenia (<50K) or coagulopathy (prothrombin time >18 seconds).End stage liver disease.Active intracranial lesions/neoplasms.Hypertensive urgency/emergency.Post-operative bleeding concerns**Immune mediated heparin-induced thrombocytopenia.Epidural analgesia with spinal catheter (current or planned).** Scheduled return to OR within the next 24 hours: major ortho: 24 hours leeway; spinal cord or ortho spine: 7 days leeway; general surgery, status post transplant, status post trauma admission: 48 hours leeway. Current as of August 2008 Internet Citation: Appendix D. Chart Audit Form: Preventing Hospital-Acquired Venous Thromboembolism. August 2008. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/professionals/quality-patient-safety/patient-safety-resources/resources/vtguide/vtguideapd.html